Lingamneni Anila's Form 4 filing
Haemonetics Corp (HAE) · filed Jul 15, 2024
- Accession no.
- 0001127602-24-020383
- Filed
- Jul 15, 2024
- Trade date
- Jul 11-12, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $199.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lingamneni AnilaCIK 0001808414 | Officer (EVP, Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2024 | Common Stock | SSaleDisposed | −2,136 | $90.00 | −$192,240 | 21,410 | Direct | |
| Jul 12, 2024 | Common Stock | SSaleDisposed | −79 | $90.00 | −$7,110 | 21,331 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.